CNBC Television
@CNBCtelevision·3.4M subscribers·157.5K videos
Red Flag Over Biogen's Expensive Drug For Rare Genetic Disease | Power Lunch | CNBC
Posted
December 29, 2016
Views
1,361
Likes
5
Engagement
0.37%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
YouTube Description
as posted by the channelCNBC's Meg Tirrell reports that one analyst is raising a red flag on Biogen due to the incredibly high price of a new drug to treat a rare genetic disease in children.
» Subscribe to CNBC
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Connect with CNBC News Online
Get the latest news
Find CNBC News on Facebook
Follow CNBC News on Twitter
Follow CNBC News on Google+
Follow CNBC News on Instagram
Red Flag Over Biogen's Expensive Drug For Rare Genetic Disease | Power Lunch | CNBC
Links & Promotions
Guests & Subjects Covered
CNBC's Meg TirrellCNBC About CNBC FromReality TVCNBC News Online GetFind CNBC NewsFacebook Follow CNBC NewsTwitter Follow CNBC NewsGoogle Follow CNBC News
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.